139 related articles for article (PubMed ID: 17641468)
21. Prion infection of mouse neurospheres.
Giri RK; Young R; Pitstick R; DeArmond SJ; Prusiner SB; Carlson GA
Proc Natl Acad Sci U S A; 2006 Mar; 103(10):3875-80. PubMed ID: 16495413
[TBL] [Abstract][Full Text] [Related]
22. Octapeptide repeat region of prion protein (PrP) is required at an early stage for production of abnormal prion protein in PrP-deficient neuronal cell line.
Sakudo A; Wu G; Onodera T; Ikuta K
Biochem Biophys Res Commun; 2008 Jan; 365(1):164-9. PubMed ID: 17981146
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of PrP(Sc) formation in scrapie infected N2a cells by 5,7,8-trimethyl-3,4-dihydro-2H-1,4-benzoxazine derivatives.
Koukouli F; Paspaltsis I; Salta E; Xanthopoulos K; Koini EN; Calogeropoulou T; Sklaviadis T
Prion; 2012; 6(5):470-6. PubMed ID: 22918434
[TBL] [Abstract][Full Text] [Related]
24. Prion infection impairs lysosomal degradation capacity by interfering with rab7 membrane attachment in neuronal cells.
Shim SY; Karri S; Law S; Schatzl HM; Gilch S
Sci Rep; 2016 Feb; 6():21658. PubMed ID: 26865414
[TBL] [Abstract][Full Text] [Related]
25. Copper binding to PrPC may inhibit prion disease propagation.
Hijazi N; Shaked Y; Rosenmann H; Ben-Hur T; Gabizon R
Brain Res; 2003 Dec; 993(1-2):192-200. PubMed ID: 14642846
[TBL] [Abstract][Full Text] [Related]
26. Charged bipolar suramin derivatives induce aggregation of the prion protein at the cell surface and inhibit PrPSc replication.
Nunziante M; Kehler C; Maas E; Kassack MU; Groschup M; Schätzl HM
J Cell Sci; 2005 Nov; 118(Pt 21):4959-73. PubMed ID: 16219680
[TBL] [Abstract][Full Text] [Related]
27. The charge structure of helix 1 in the prion protein regulates conversion to pathogenic PrPSc.
Norstrom EM; Mastrianni JA
J Virol; 2006 Sep; 80(17):8521-9. PubMed ID: 16912302
[TBL] [Abstract][Full Text] [Related]
28. Role of cell death in the propagation of PrP(Sc) in immune cells.
Takahashi K; Inoshima Y; Ishiguro N
Arch Virol; 2015 Mar; 160(3):693-9. PubMed ID: 25559669
[TBL] [Abstract][Full Text] [Related]
29. Clearance and prevention of prion infection in cell culture by anti-PrP antibodies.
Pankiewicz J; Prelli F; Sy MS; Kascsak RJ; Kascsak RB; Spinner DS; Carp RI; Meeker HC; Sadowski M; Wisniewski T
Eur J Neurosci; 2006 May; 23(10):2635-47. PubMed ID: 16817866
[TBL] [Abstract][Full Text] [Related]
30. Successful transmission of three mouse-adapted scrapie strains to murine neuroblastoma cell lines overexpressing wild-type mouse prion protein.
Nishida N; Harris DA; Vilette D; Laude H; Frobert Y; Grassi J; Casanova D; Milhavet O; Lehmann S
J Virol; 2000 Jan; 74(1):320-5. PubMed ID: 10590120
[TBL] [Abstract][Full Text] [Related]
31. Stimulation of PrP(C) retrograde transport toward the endoplasmic reticulum increases accumulation of PrP(Sc) in prion-infected cells.
Béranger F; Mangé A; Goud B; Lehmann S
J Biol Chem; 2002 Oct; 277(41):38972-7. PubMed ID: 12163492
[TBL] [Abstract][Full Text] [Related]
32. Cellular prion protein (PrPC) protects neuronal cells from the effect of huntingtin aggregation.
Lee KJ; Panzera A; Rogawski D; Greene LE; Eisenberg E
J Cell Sci; 2007 Aug; 120(Pt 15):2663-71. PubMed ID: 17635996
[TBL] [Abstract][Full Text] [Related]
33. Expression of unglycosylated mutated prion protein facilitates PrP(Sc) formation in neuroblastoma cells infected with different prion strains.
Korth C; Kaneko K; Prusiner SB
J Gen Virol; 2000 Oct; 81(Pt 10):2555-2563. PubMed ID: 10993946
[TBL] [Abstract][Full Text] [Related]
34. Cooperative binding of dominant-negative prion protein to kringle domains.
Ryou C; Prusiner SB; Legname G
J Mol Biol; 2003 May; 329(2):323-33. PubMed ID: 12758079
[TBL] [Abstract][Full Text] [Related]
35. Possible involvement of calpain-like activity in normal processing of cellular prion protein.
Hachiya N; Komata Y; Harguem S; Nishijima K; Kaneko K
Neurosci Lett; 2011 Feb; 490(2):150-5. PubMed ID: 21193014
[TBL] [Abstract][Full Text] [Related]
36. Development of oligomeric prion-protein aggregates in a mouse model of prion disease.
Sasaki K; Minaki H; Iwaki T
J Pathol; 2009 Sep; 219(1):123-30. PubMed ID: 19479969
[TBL] [Abstract][Full Text] [Related]
37. Testing the possibility to protect bovine PrPC transgenic Swiss mice against bovine PrPSc infection by DNA vaccination using recombinant plasmid vectors harboring and expressing the complete or partial cDNA sequences of bovine PrPC.
Müller S; Kehm R; Handermann M; Jakob NJ; Bahr U; Schröder B; Darai G
Virus Genes; 2005 Mar; 30(2):279-96. PubMed ID: 15744583
[TBL] [Abstract][Full Text] [Related]
38. A camelid anti-PrP antibody abrogates PrP replication in prion-permissive neuroblastoma cell lines.
Jones DR; Taylor WA; Bate C; David M; Tayebi M
PLoS One; 2010 Mar; 5(3):e9804. PubMed ID: 20339552
[TBL] [Abstract][Full Text] [Related]
39. Prion protein facilitates retinal iron uptake and is cleaved at the β-site: Implications for retinal iron homeostasis in prion disorders.
Asthana A; Baksi S; Ashok A; Karmakar S; Mammadova N; Kokemuller R; Greenlee MH; Kong Q; Singh N
Sci Rep; 2017 Aug; 7(1):9600. PubMed ID: 28851903
[TBL] [Abstract][Full Text] [Related]
40. Soluble dimeric prion protein binds PrP(Sc) in vivo and antagonizes prion disease.
Meier P; Genoud N; Prinz M; Maissen M; Rülicke T; Zurbriggen A; Raeber AJ; Aguzzi A
Cell; 2003 Apr; 113(1):49-60. PubMed ID: 12679034
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
